WO2002039924A2 - Endovascular prosthesis - Google Patents
Endovascular prosthesis Download PDFInfo
- Publication number
- WO2002039924A2 WO2002039924A2 PCT/CA2001/001587 CA0101587W WO0239924A2 WO 2002039924 A2 WO2002039924 A2 WO 2002039924A2 CA 0101587 W CA0101587 W CA 0101587W WO 0239924 A2 WO0239924 A2 WO 0239924A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- porous section
- tubular wall
- endovascular prosthesis
- annular portion
- method defined
- Prior art date
Links
- 239000000463 material Substances 0.000 claims abstract description 49
- 208000025494 Aortic disease Diseases 0.000 claims abstract description 30
- 238000002513 implantation Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 32
- 208000002251 Dissecting Aneurysm Diseases 0.000 claims description 22
- 206010002895 aortic dissection Diseases 0.000 claims description 20
- 206010065558 Aortic arteriosclerosis Diseases 0.000 claims description 9
- 208000014674 injury Diseases 0.000 claims description 9
- 230000008733 trauma Effects 0.000 claims description 9
- 230000000903 blocking effect Effects 0.000 claims description 7
- 229910001285 shape-memory alloy Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims 2
- 239000002861 polymer material Substances 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 abstract description 6
- 210000000709 aorta Anatomy 0.000 description 26
- 238000002224 dissection Methods 0.000 description 26
- 206010018852 Haematoma Diseases 0.000 description 18
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 208000032843 Hemorrhage Diseases 0.000 description 11
- 210000002376 aorta thoracic Anatomy 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 208000025865 Ulcer Diseases 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000642 iatrogenic effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000013175 transesophageal echocardiography Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 230000036269 ulceration Effects 0.000 description 4
- 206010060874 Aortic rupture Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002608 intravascular ultrasound Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 210000000278 spinal cord Anatomy 0.000 description 3
- 206010002899 Aortic injury Diseases 0.000 description 2
- 206010033892 Paraplegia Diseases 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000003129 brachiocephalic vein Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 210000001604 vasa vasorum Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 208000026828 Aorta coarctation Diseases 0.000 description 1
- 208000006179 Aortic Coarctation Diseases 0.000 description 1
- 206010057453 Aortic dilatation Diseases 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- 241001092081 Carpenteria Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010009807 Coarctation of the aorta Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000001750 Endoleak Diseases 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- 208000009087 False Aneurysm Diseases 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- 206010049941 Mediastinal haematoma Diseases 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000030922 Tibial Meniscus injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002168 brachiocephalic trunk Anatomy 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical group C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
- A61F2250/0024—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity made from both porous and non-porous parts, e.g. adjacent parts
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002542301A JP2004512920A (en) | 2000-11-17 | 2001-11-19 | Endovascular prosthesis |
CA2428742A CA2428742C (en) | 2000-11-17 | 2001-11-19 | Endovascular prosthesis |
AU2002223326A AU2002223326A1 (en) | 2000-11-17 | 2001-11-19 | Endovascular prosthesis |
US10/416,819 US20040116998A1 (en) | 2001-11-19 | 2001-11-19 | Endovascular prosthesis |
EP01996343A EP1337197A2 (en) | 2000-11-17 | 2001-11-19 | Endovascular prosthesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24928800P | 2000-11-17 | 2000-11-17 | |
US60/249,288 | 2000-11-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002039924A2 true WO2002039924A2 (en) | 2002-05-23 |
WO2002039924A3 WO2002039924A3 (en) | 2002-12-27 |
WO2002039924A8 WO2002039924A8 (en) | 2003-07-03 |
Family
ID=22942829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2001/001587 WO2002039924A2 (en) | 2000-11-17 | 2001-11-19 | Endovascular prosthesis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1337197A2 (en) |
JP (1) | JP2004512920A (en) |
AU (1) | AU2002223326A1 (en) |
CA (1) | CA2428742C (en) |
WO (1) | WO2002039924A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1420729A2 (en) * | 2001-07-18 | 2004-05-26 | The Research Foundation Of State University Of New York | Stent vascular intervention device and method |
WO2012145826A1 (en) | 2011-04-29 | 2012-11-01 | Evysio Medical Devices Ulc | Endovascular prosthesis and delivery device |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2360185T3 (en) * | 2005-09-01 | 2011-06-01 | Medtronic Vascular, Inc. | METHODS AND APPARATUS FOR THE TREATMENT OF AORTA TORÁCICA ANEURISMS. |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
US5037392A (en) | 1989-06-06 | 1991-08-06 | Cordis Corporation | Stent-implanting balloon assembly |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464449A (en) * | 1993-07-08 | 1995-11-07 | Thomas J. Fogarty | Internal graft prosthesis and delivery system |
US5609628A (en) * | 1995-04-20 | 1997-03-11 | Keranen; Victor J. | Intravascular graft and catheter |
US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US6258115B1 (en) * | 1997-04-23 | 2001-07-10 | Artemis Medical, Inc. | Bifurcated stent and distal protection system |
US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US6030414A (en) * | 1997-11-13 | 2000-02-29 | Taheri; Syde A. | Variable stent and method for treatment of arterial disease |
US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
IL128938A0 (en) * | 1999-03-11 | 2000-02-17 | Mind Guard Ltd | Implantable stroke treating device |
-
2001
- 2001-11-19 WO PCT/CA2001/001587 patent/WO2002039924A2/en active Application Filing
- 2001-11-19 CA CA2428742A patent/CA2428742C/en not_active Expired - Fee Related
- 2001-11-19 EP EP01996343A patent/EP1337197A2/en not_active Withdrawn
- 2001-11-19 AU AU2002223326A patent/AU2002223326A1/en not_active Abandoned
- 2001-11-19 JP JP2002542301A patent/JP2004512920A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4739762A (en) | 1985-11-07 | 1988-04-26 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665B1 (en) | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4739762B1 (en) | 1985-11-07 | 1998-10-27 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US5037392A (en) | 1989-06-06 | 1991-08-06 | Cordis Corporation | Stent-implanting balloon assembly |
US5035706A (en) | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1420729A2 (en) * | 2001-07-18 | 2004-05-26 | The Research Foundation Of State University Of New York | Stent vascular intervention device and method |
EP1420729A4 (en) * | 2001-07-18 | 2007-03-21 | Univ New York State Res Found | Stent vascular intervention device and method |
WO2012145826A1 (en) | 2011-04-29 | 2012-11-01 | Evysio Medical Devices Ulc | Endovascular prosthesis and delivery device |
US9056024B2 (en) | 2011-04-29 | 2015-06-16 | Evasc Neurovascular Limited Partnership | Endovascular prosthesis and delivery device |
US9345598B2 (en) | 2011-04-29 | 2016-05-24 | Evasc Neurovascular Limited Partnership | Endovascular prosthesis and delivery device |
US10987237B2 (en) | 2011-04-29 | 2021-04-27 | Evasc Neurovascular Enterprises Ulc | Endovascular prosthesis and delivery device |
EP3865099A1 (en) | 2011-04-29 | 2021-08-18 | Evasc Neurovascular Enterprises ULC | Endovascular prosthesis |
Also Published As
Publication number | Publication date |
---|---|
AU2002223326A1 (en) | 2002-05-27 |
JP2004512920A (en) | 2004-04-30 |
EP1337197A2 (en) | 2003-08-27 |
CA2428742A1 (en) | 2002-05-23 |
CA2428742C (en) | 2014-07-22 |
WO2002039924A8 (en) | 2003-07-03 |
WO2002039924A3 (en) | 2002-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7959662B2 (en) | Endovascular prosthesis | |
US11033378B2 (en) | Medical device | |
JP3215807B2 (en) | Expandable stent | |
US6969401B1 (en) | Endovascular prosthesis | |
CA1338303E (en) | Expandable Intraluminal Graft and Apparatus for Implanting an Expandable Intraluminal Graft | |
US5782907A (en) | Involuted spring stent and graft assembly and method of use | |
US9119737B2 (en) | Twisting bifurcation delivery system | |
US20050049678A1 (en) | Stent | |
JP2003093518A (en) | Intravascular stent | |
JPH1119219A (en) | Stent | |
US20070213811A1 (en) | Bifurcated stent with improvement securement | |
EP1968504A1 (en) | Bifurcated stent with multiple side branch access | |
US20040116998A1 (en) | Endovascular prosthesis | |
EP1928368B1 (en) | Hybrid bifurcated stent | |
CA2428742C (en) | Endovascular prosthesis | |
AU2011200383A1 (en) | Endovascular prosthesis | |
AU2011226975A1 (en) | Endovascular prosthesis | |
AU2011226974A1 (en) | Endovascular prosthesis | |
AU2002331423A1 (en) | A stent | |
AU2008201840A1 (en) | A stent | |
AU2009202392A1 (en) | Endovascular prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2428742 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002542301 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001996343 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002223326 Country of ref document: AU |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 21/2002 UNDER (71, 72) DELETE "PENN, IAN,M. [CA/CA]; 4511 BELLEVUE DRIVE, VANCOUVER, BRITISH COLUMBIA V6R 1E4 (CA)."; UNDER (72, 75) ADD "PENN, IAN, M. [CA/CA]; 4511 BELLEVUE DRIVE, VANCOUVER, BRITISH COLUMBIA V6R 1E4 (CA)." |
|
WWP | Wipo information: published in national office |
Ref document number: 2001996343 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10416819 Country of ref document: US |